Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
16 January, 2019 12:03 IST
Cadila Healthcare's Moraiya facility completes USFDA inspection
Source: IRIS | 12 Feb, 2018, 12.51PM
Comments  |  Post Comment

Cadila Healthcare announced that the USFDA inspected its Moraiya facility from February 5th to February 9th, 2018.  At the end of the inspection, no observation (483) is issued.

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies. The group employs over 21000 people worldwide and is dedicated to creating healthier communities globally. Zydus aspires to be a research-based pharmaceutical company by 2020.

Shares of the company gained Rs 13.35, or 3.25%, to trade at Rs 424.40. The total volume of shares traded was 68,658 at the BSE (12.38 p.m., Monday).



Cadila Healthcare Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Dr Reddys announces completion of USFDA audit of its formulation facility in Andhra Pradesh - 16-Jan-2019 10:15
L&T Hydrocarbon consortium wins EPCI order from Saudi Aramco - 15-Jan-2019 10:24
Zydus Cadila gets final approval from USFDA for 2 drugs - 15-Jan-2019 10:20
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer